These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
466 related articles for article (PubMed ID: 25348361)
1. DNA-PKcs deficiency sensitizes the human hepatoma HepG2 cells to cisplatin and 5-fluorouracil through suppression of the PI3K/Akt/NF-κB pathway. Fang Y; Chai Z; Wang D; Kuang T; Wu W; Lou W Mol Cell Biochem; 2015 Jan; 399(1-2):269-78. PubMed ID: 25348361 [TBL] [Abstract][Full Text] [Related]
2. Hexabromocyclododecane and polychlorinated biphenyls increase resistance of hepatocellular carcinoma cells to cisplatin through the phosphatidylinositol 3-kinase/protein kinase B pathway. An J; Wang X; Guo P; Zhong Y; Zhang X; Yu Z Toxicol Lett; 2014 Aug; 229(1):265-72. PubMed ID: 24960055 [TBL] [Abstract][Full Text] [Related]
3. Camel Milk Ameliorates 5-Fluorouracil-Induced Renal Injury in Rats: Targeting MAPKs, NF-κB and PI3K/Akt/eNOS Pathways. Arab HH; Salama SA; Maghrabi IA Cell Physiol Biochem; 2018; 46(4):1628-1642. PubMed ID: 29694984 [TBL] [Abstract][Full Text] [Related]
4. [Wogonoside reverses cisplatin resistance in SGC7901/cDDP cells through inhibition of PI3K/Akt/Nrf2/ARE signaling pathway]. Wang LJ; Wang SG; Deng TX Sheng Li Xue Bao; 2018 Aug; 70(4):397-405. PubMed ID: 30112565 [TBL] [Abstract][Full Text] [Related]
5. Synergistic induction of ICAM-1 expression by cisplatin and 5-fluorouracil in a cancer cell line via a NF-kappaB independent pathway. Takizawa K; Kamijo R; Ito D; Hatori M; Sumitani K; Nagumo M Br J Cancer; 1999 Jun; 80(7):954-63. PubMed ID: 10362102 [TBL] [Abstract][Full Text] [Related]
6. Role of intracellular glutathione in cell sensitivity to the apoptosis induced by tumor necrosis factor {alpha}-related apoptosis-inducing ligand/anticancer drug combinations. Meurette O; Lefeuvre-Orfila L; Rebillard A; Lagadic-Gossmann D; Dimanche-Boitrel MT Clin Cancer Res; 2005 Apr; 11(8):3075-83. PubMed ID: 15837763 [TBL] [Abstract][Full Text] [Related]
7. Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathways. Gao Y; Xiao X; Zhang C; Yu W; Guo W; Zhang Z; Li Z; Feng X; Hao J; Zhang K; Xiao B; Chen M; Huang W; Xiong S; Wu X; Deng W J Pineal Res; 2017 Mar; 62(2):. PubMed ID: 27865009 [TBL] [Abstract][Full Text] [Related]
8. Kanglaite enhances the efficacy of cisplatin in suppression of hepatocellular carcinoma via inhibiting CKLF1 mediated NF-κB pathway and regulating transporter mediated drug efflux. Chen C; Ai QD; Wei YH J Ethnopharmacol; 2021 Jan; 264():113388. PubMed ID: 32918990 [TBL] [Abstract][Full Text] [Related]
9. Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway. Yu M; Qi B; Xiaoxiang W; Xu J; Liu X Biomed Pharmacother; 2017 Jun; 90():677-685. PubMed ID: 28415048 [TBL] [Abstract][Full Text] [Related]
10. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma. Kim R; Tanabe K; Inoue H; Toge T Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567 [TBL] [Abstract][Full Text] [Related]
11. CD133 and DNA-PK regulate MDR1 via the PI3K- or Akt-NF-κB pathway in multidrug-resistant glioblastoma cells in vitro. Xi G; Hayes E; Lewis R; Ichi S; Mania-Farnell B; Shim K; Takao T; Allender E; Mayanil CS; Tomita T Oncogene; 2016 Jan; 35(2):241-50. PubMed ID: 25823028 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of MALAT1 sensitizes liver cancer cells to 5-flurouracil by regulating apoptosis through IKKα/NF-κB pathway. Ji DG; Guan LY; Luo X; Ma F; Yang B; Liu HY Biochem Biophys Res Commun; 2018 Jun; 501(1):33-40. PubMed ID: 29702091 [TBL] [Abstract][Full Text] [Related]
13. MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer. Cortes-Sempere M; Chattopadhyay S; Rovira A; Rodriguez-Fanjul V; Belda-Iniesta C; Tapia M; Cejas P; Machado-Pinilla R; Manguan-García C; Sánchez-Pérez I; Nistal M; Moratilla C; de Castro-Carpeño J; Gonzalez-Barón M; Albanell J; Perona R Cancer Lett; 2009 Dec; 286(2):206-16. PubMed ID: 19553005 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of DNA-PKcs suppresses P-gp expression via inhibition of the Akt/NF-κB pathway in CD133-positive osteosarcoma MG-63 cells. Li K; Li X; Tian J; Wang H; Pan J; Li J Oncol Rep; 2016 Oct; 36(4):1973-80. PubMed ID: 27499034 [TBL] [Abstract][Full Text] [Related]
15. PDCD6 additively cooperates with anti-cancer drugs through activation of NF-κB pathways. Park SH; Lee JH; Lee GB; Byun HJ; Kim BR; Park CY; Kim HB; Rho SB Cell Signal; 2012 Mar; 24(3):726-33. PubMed ID: 22142513 [TBL] [Abstract][Full Text] [Related]
16. Hydrazinocurcumin and 5-fluorouracil enhance apoptosis and restrain tumorigenicity of HepG2 cells via disrupting the PTEN-mediated PI3K/Akt signaling pathway. Zhou Y; Zhang M; Zhang Z; Jia Y; Zhang C; Peng L Biomed Pharmacother; 2020 Sep; 129():109851. PubMed ID: 32559627 [TBL] [Abstract][Full Text] [Related]
17. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance. Brenes O; Arce F; Gätjens-Boniche O; Díaz C Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942 [TBL] [Abstract][Full Text] [Related]
18. LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells. Shin JY; Kim JO; Lee SK; Chae HS; Kang JH BMC Cancer; 2010 Aug; 10():425. PubMed ID: 20704765 [TBL] [Abstract][Full Text] [Related]
19. Rosmarinic acid sensitizes cell death through suppression of TNF-alpha-induced NF-kappaB activation and ROS generation in human leukemia U937 cells. Moon DO; Kim MO; Lee JD; Choi YH; Kim GY Cancer Lett; 2010 Feb; 288(2):183-91. PubMed ID: 19619938 [TBL] [Abstract][Full Text] [Related]
20. p53 restoration can overcome cisplatin resistance through inhibition of Akt as well as induction of Bax. Kim CW; Lu JN; Go SI; Jung JH; Yi SM; Jeong JH; Hah YS; Han MS; Park JW; Lee WS; Min YJ Int J Oncol; 2013 Nov; 43(5):1495-502. PubMed ID: 23970333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]